已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

An immune checkpoint-based signature predicts prognosis and chemotherapy response for patients with small cell lung cancer

肿瘤科 免疫检查点 医学 内科学 肺癌 化疗 比例危险模型 免疫系统 恶性肿瘤 免疫疗法 癌症 免疫学
作者
Le Wang,Peng Wu,Zhibo Shen,Qiuning Yu,Yulin Zhang,Fanglei Ye,Kuisheng Chen,Jie Zhao
出处
期刊:International Immunopharmacology [Elsevier BV]
卷期号:117: 109827-109827 被引量:5
标识
DOI:10.1016/j.intimp.2023.109827
摘要

Therapeutic options for small cell lung cancer (SCLC), a particularly lethal malignancy, remain limited. Members of the B7-CD28 family are compelling targets for immune checkpoint blockade strategies, which involve activating, inhibiting, and fine-tuning the T cell immune response. However, their clinical features and significance have not been explored comprehensively.We enrolled 228 patients with an initial diagnosis of SCLC, including 77 cases from Cbioportal and a validation cohort of 151 cases with qPCR data. Kaplan-Meier analysis and LASSO Cox model were used to identify a signature based on the B7-CD28 family, which was applied for accurate prediction of chemotherapy benefit and prognosis for SCLC patients. In addition, we applied bioinformatics analysis to explore potential signature-related molecular mechanisms and the immune landscape.The mutation profiles of healthy tissues and SCLC tissues were distinct. A signature consisting of seven genes (CD86, ICOSLG, CD276, CD28, CTLA-4, PDCD1, and TMIGD2) was identified and applied to group patients based on risk level (high-risk and low-risk), producing two groups for which survival outcomes differed significantly (HR = 3.81, 95% CI: 2.16-6.74, P < 0.001). The immune checkpoint-based signature accurately predicted patient outcomes for the selected training and validation sets. Notably, low-risk patients were more likely to benefit from chemotherapy and showed greater immune activation. Additionally, time-dependent ROC curves and C-index analysis confirmed that the immune checkpoint-based signature has excellent predictive power for prognosis and chemotherapy benefit compared to clinically recognized parameters. Finally, multivariate analysis confirmed the identified signature as an independent risk factor for prognosis and chemotherapeutic response.We systematically obtained a comprehensive molecular profile for B7-CD28 family members in SCLC patients, from which we produced a reliable and robust prognostic immune checkpoint-based signature with the potential to improve prognostic stratification and therapy strategies for SCLC patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
白鹭立雪完成签到,获得积分10
6秒前
念初发布了新的文献求助10
7秒前
搜集达人应助fu采纳,获得10
9秒前
10秒前
快乐的小叮当应助噗宝凹采纳,获得10
10秒前
充电宝应助Chi_bio采纳,获得10
10秒前
粥粥应助碧蓝的宝马采纳,获得10
10秒前
柚又完成签到 ,获得积分10
13秒前
小王顶呱呱完成签到 ,获得积分10
13秒前
15秒前
15秒前
可知发布了新的文献求助10
16秒前
16秒前
17秒前
rhei发布了新的文献求助20
18秒前
氯化氟完成签到 ,获得积分20
18秒前
zydong完成签到,获得积分10
19秒前
詹卫卫发布了新的文献求助10
20秒前
i3utter发布了新的文献求助10
21秒前
22秒前
深情安青应助AOPs采纳,获得10
22秒前
六年发布了新的文献求助30
23秒前
Dorr发布了新的文献求助10
23秒前
打打应助氯化氟采纳,获得10
24秒前
隐形曼青应助念初采纳,获得10
24秒前
一直向前发布了新的文献求助10
24秒前
丘比特应助rhei采纳,获得30
26秒前
orixero应助洛芷采纳,获得10
28秒前
29秒前
丘比特应助多年以后采纳,获得10
29秒前
zhongu发布了新的文献求助10
29秒前
恋雅颖月应助晶晶采纳,获得10
31秒前
xiaoming发布了新的文献求助200
31秒前
32秒前
洛芷完成签到,获得积分10
33秒前
Dorr完成签到,获得积分10
34秒前
34秒前
科研通AI5应助听听采纳,获得10
34秒前
菠萝完成签到 ,获得积分10
34秒前
mmyhn发布了新的文献求助10
36秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
Aktuelle Entwicklungen in der linguistischen Forschung 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989918
求助须知:如何正确求助?哪些是违规求助? 3532013
关于积分的说明 11255831
捐赠科研通 3270829
什么是DOI,文献DOI怎么找? 1805053
邀请新用户注册赠送积分活动 882233
科研通“疑难数据库(出版商)”最低求助积分说明 809216